# Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

> **NCT01845441** · PHASE2 · TERMINATED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Stroke
- Brain Ischemia
- Vasospasm, Intracranial
- Hemorrhage, Intracranial

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Fentanyl
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01845441
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The principal investigator left employment at the sponsoring Institution
- **Last updated:** 2022-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845441, "Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01845441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*